Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19
ConditionCOVID
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorTanta University
About this trial
ACEIs as treatment for COVID19
Eligibility criteria
Qualifiers
Patients infected with covid 19
Disqualifiers
allergy or contraindications to the drug
Trial design
Treatments tested in this trial
- ACEIs
- Conventional treatment
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov